In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hematology analyzers devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hematology analyzers market in the UK was Sysmex followed by Danaher, Abbott Laboratories, Horiba, Siemens Healthineers, Shenzhen Mindray Bio-Medical Electronics, EKF Diagnostics and Nihon Kohden.
Hematology Analyzers are also used to identify and determine morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Hematology Analyzers utilize various technological solutions in order to recognize cell types in a blood sample and to count them individually to generate a Complete Blood Count (CBC) with differential. The Hematology Analyzers include High-throughput Fixed Hematology Analyzers, and Medium-throughput Fixed Hematology Analyzers.
The value of the hematology analyzers devices market within the UK was expected to be over $60m in 2023.
For the latest complete market share analysis of hematology analyzers device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
